Australien - Englisch - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - lidocaine hydrochloride, quantity: 10 mg/ml - injection, solution - excipient ingredients: water for injections; sodium chloride; sodium hydroxide - xylocaine solutions are indicated for the production of local or regional anaesthesia by the following techniques; infiltration, intravenous regional anaesthesia - excluding solutions with adrenaline, peripheral nerve block such as intercostal block, major plexus block such as brachial plexus block, epidural block, subarachnoid block

Australien - Englisch - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - lidocaine hydrochloride, quantity: 5 mg/ml; adrenaline (epinephrine) acid tartrate, quantity: 9.1 microgram/ml (equivalent: adrenaline (epinephrine), qty 5 microgram/ml) - injection, solution - excipient ingredients: water for injections; sodium chloride; sodium metabisulfite; hydrochloric acid; sodium hydroxide - xylocaine solutions are indicated for the production of local or regional anaesthesia by the following techniques: infiltration, intravenous regional anaesthesia - excluding solutions with adrenaline, peripheral nerve block such as intercostal block, major plexus block such as brachial plexus block, epidural block, subarachnoid block.

Neuseeland - Englisch - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - lidocaine hydrochloride monohydrate 21.3mg equivalent to 20 mg lignocaine hydrochloride anhydrous; lidocaine hydrochloride monohydrate 21.3 mg/g equivalent to 20 mg lignocaine hydrochloride anhydrous - topical gel - 2% w/v - active: lidocaine hydrochloride monohydrate 21.3mg equivalent to 20 mg lignocaine hydrochloride anhydrous excipient: hydrochloric acid methyl hydroxybenzoate methylcellulose propyl hydroxybenzoate purified water sodium hydroxide active: lidocaine hydrochloride monohydrate 21.3 mg/g equivalent to 20 mg lignocaine hydrochloride anhydrous excipient: hydrochloric acid hypromellose methyl hydroxybenzoate propyl hydroxybenzoate purified water sodium hydroxide - xylocaine 2% jelly is indicated as a surface anaesthetic and lubricant for: · the male and female urethra during cystoscopy, catheterisation, exploration by sound and other endourethral procedures. · nasal and pharyngeal cavities in endoscopic procedures such as gastroscopy and bronchoscopy. · during proctoscopy and rectoscopy. · tracheal intubation. · to relieve pain after circumcision in children.

Singapur - Englisch - HSA (Health Sciences Authority)

dch auriga singapore - lignocaine hcl - gel - 20 mg/g - lignocaine hcl 20 mg/g

Kanada - Englisch - Health Canada

aspen pharmacare canada inc. - lidocaine hydrochloride - gel - 20mg - lidocaine hydrochloride 20mg - antipruritics and local anesthetics

Kanada - Englisch - Health Canada

aspen pharmacare canada inc. - lidocaine hydrochloride - gel - 20mg - lidocaine hydrochloride 20mg - antipruritics and local anesthetics

Australien - Englisch - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - lidocaine hydrochloride, quantity: 20 mg/ml; adrenaline (epinephrine) acid tartrate, quantity: 22.7 microgram/ml (equivalent: adrenaline (epinephrine), qty microgram/ml) - injection, solution - excipient ingredients: sodium metabisulfite; water for injections; sodium chloride; hydrochloric acid; sodium hydroxide - xylocaine solutions are indicated for the production of local or regional anaesthesia by the following techniques: infiltration, intravenous regional anaesthesia - excluding solutions with adrenaline, peripheral nerve block such as intercostal block, major plexus block such as brachial plexus block, epidural block, subarachnoid block.

Belgien - Englisch - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

aspen pharma trading ltd. - lidocaine hydrochloride 20 mg - urethral gel - 2 % - lidocaine hydrochloride 20 mg/ml - lidocaine

Belgien - Englisch - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

aspen pharma trading ltd. - lidocaine hydrochloride 20 mg - urethral gel - 2 % - lidocaine hydrochloride 20 mg/g - lidocaine

Vereinigte Staaten - Englisch - NLM (National Library of Medicine)

oak pharmaceuticals, inc. (subsidiary of akorn, inc.) - lidocaine hydrochloride (unii: v13007z41a) (lidocaine - unii:98pi200987) - lidocaine hydrochloride 0.5 mg in 18 ml - xylocaine (lidocaine hcl) 2% jelly is indicated for prevention and control of pain in procedures involving the male and female urethra, for topical treatment of painful urethritis, and as an anesthetic lubricant for endotracheal intubation (oral and nasal). lidocaine is contraindicated in patients with a known history of hypersensitivity to local anesthetics of the amide type or to other components of xylocaine 2% jelly.